Read more at CNBC.
Most people on weight loss drugs are spending less on restaurants and takeout, survey says
Date: |
Sort by
Filter
Date
Items per page
-
Amgen ‘very encouraged’ by data from weight-loss-drug trial, as stock jumps
Shares of Amgen Inc. rallied in the extended session Thursday after the drug maker posted adjusted earnings above expectations and executives said they are “very encouraged” by preliminary data from a trial of an injectable weight-loss drug.MarketWatch - Business -
Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide
Amgen's update fueled concerns about potential new competition in the weight loss drug market, sending shares of Novo Nordisk and Eli Lilly lower.CNBC - Business
More from CNBC
-
Berkshire Hathaway’s big mystery stock wager could be revealed soon
Warren Buffett's bet, shrouded in mystery, has captivated Berkshire Hathaway investors since first appearing in disclosures late last year.CNBC - Business -
Here's where the jobs are for April 2024 — in one chart
Health care and social assistance led the way, while construction hiring slowed.CNBC - Business -
Apple stock has best day since 2022 after earnings beat, $110 billion stock buyback
Apple shares popped on Friday after the company reported better-than-expected second-quarter earnings and the largest-ever stock buyback program.CNBC - Business - Apple -
SEC charges Trump Media auditor with 'massive fraud' on hundreds of companies, imposes lifetime ban
Trump Media, the owner of the Truth Social app, trades under the DJT ticker. Former President Donald Trump is the majority shareholder of the company.CNBC - Business - Donald Trump -
U.S. job growth totaled 175,000 in April, much less than expected, while unemployment rose to 3.9%
Markets had expected job growth of 240,000 and the unemployment rate to hold at 3.8%.CNBC - Business